Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy.
Georg SchlachtenbergerAntje Christin DeppeStephen GerferYeong-Hoon ChoiMohamed ZeriouhOliver LiakopoulosThorsten C W WahlersPublished in: The Thoracic and cardiovascular surgeon (2020)
Dual antiplatelet therapy is associated with higher rates of major bleeding. Further studies should examine the difference in the prevalence of major bleeding complications in the different dual antiplatelet therapy regimes in patients requiring urgent surgery.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- atrial fibrillation
- coronary artery bypass
- end stage renal disease
- coronary artery disease
- coronary artery bypass grafting
- risk factors
- chronic kidney disease
- minimally invasive
- newly diagnosed
- prognostic factors
- patient reported
- case control